AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Present AI Drug Discovery Platforms at Inaugural AI4BM Symposium
Lantern Pharma (NASDAQ: LTRN) will present its commercially deployed AI research platforms, predictBBB.ai and LBx-AI, at the inaugural AI for Biology and Medicine symposium hosted by the University of North Texas. The company will showcase how machine learning is accelerating drug development and precision oncology, including 94.1% accuracy in predicting blood-brain barrier permeability and 86% accuracy in treatment response prediction for non-small cell lung cancer. CEO Panna Sharma said the presentations highlight Lantern’s mission to democratize advanced computational tools and reshape how pharmaceutical companies approach discovery, biomarker development, and CNS-targeted therapeutics. To view the full press release, visit https://ibn.fm/UpeZx About…